Immunonutritional therapy in liver transplant patients - a randomised trial

A randomised, double-blind trial to investigate effects of an immunonutritional supplement (Impact) versus an isonitrogenous, isocaloric control provided pre- and postoperatively to patients undergoing liver transplantation on pre-transplant nutritional status and post-transplant recovery.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000449639

Enrollment

100

Registered

2005-09-21

Start date

2001-11-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Single-centre, randomised, double-blind, study comparing nutritional supplementation with Impact (Novartis).

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

Listed for elective liver transplantation; written informed consent.

Exclusion criteria

Re-transplant, acute liver failure, pregnancy.

Outcome results